Combination of darunavir with corticosteroids should be avoided because either the inhibition of CYP3A4 increase the risk for Cushing’s syndrome or the induction of CYP3A4 from corticosteroids may reduce the concentration of darunavir [35,86]. This evidence concerns the gene CYP3A4 and Cushing syndrome due to macronodular adrenal hyperplasia.